Ceftolozane (formerly CXA101; FR264205; CXA-101; FR-264205; Zerbaxa) is a semi-synthetic beta-lactam and 5th generation cephalosporin antibiotic with the potential for the treatment of UTIs (urinary tract infections) and infections caused by gram-negative bacteria, or gram-positive bacteria. The combination of Ceftolozane with the β-lactamase inhibitor tazobactam (trade name Zerbaxa) has been approved in 2014 to treat multi-drug resistant bacterial infections that show resistance to all β-lactam antibiotics.

纯度：≥98%

CAS：689293-68-3